Abstract
High clinic blood pressure (BP), male sex, cigarette smoking, dyslipidemia, renal function, anemia and thiazolidenediones (TZD) treatment are known predictors for clinically significant diabetic macula edema (CSDME). This study was performed to identify the most significant risk factors for CSDME in Japanese patients with type 2 diabetes mellitus (T2DM) and retinopathy (DR), using optical coherence tomography (OCT) if necessary, by multiple regression analysis. One of the risk factors was BP in awakening.
Seven diabetic Japanese patients with CSDME (group 1) and 124 subjects without CSDME (group 2) with DR on OCT were studied.
The durations of T2DM in groups 1 and 2 were 15 ± 10 years and 20 ± 15 years, respectively. There was no significant difference in sex distribution, duration, age, body mass index (BMI), and HbA1c, lipids (TC, LDL, TC/HDL), creatinine and Hb levels, urinary albumin excretion rate, cigarette smoking, and clinic BP between two groups. Morning systolic home BP (MSHBP) and foveal thickness were significantly (p<0.001) greater in group 1 than in group 2, and visual acuity was significantly (p<0.001) lower in group 1 than group 2. The patients in both groups had received various kinds of drugs for hyperglycemia, hypertension and others. There were no significant differences in the prevalence of other variables between two groups.
On multiple regression analysis, MSHBP and nephropathy were significantly (p <0.03) positive predictors for CSDME, while BMI had a significantly (p <0.001) negative predictor. Other variables were not significantly correlated to CSDME.
Thus, MSHBP is a predictive factor for CSDME that can be added to the previously reported risk factors in patient with T2DM.
Keywords: Type 2 diabetes mellitus, Risk factors, Diabetic retinopathy, Diabetic macular edema, Clinically significant diabetic macula edema (CSDME), Morning home blood pressure, Clinic blood pressure
Current Diabetes Reviews
Title:Identifying Risk Factors for Clinically Significant Diabetic Macula Edema in Patients with Type 2 Diabetes Mellitus
Volume: 9 Issue: 3
Author(s): Kyuzi Kamoi, Keiji Takeda, Kaoru Hashimoto, Reiko Tanaka and Shinya Okuyama
Affiliation:
Keywords: Type 2 diabetes mellitus, Risk factors, Diabetic retinopathy, Diabetic macular edema, Clinically significant diabetic macula edema (CSDME), Morning home blood pressure, Clinic blood pressure
Abstract: High clinic blood pressure (BP), male sex, cigarette smoking, dyslipidemia, renal function, anemia and thiazolidenediones (TZD) treatment are known predictors for clinically significant diabetic macula edema (CSDME). This study was performed to identify the most significant risk factors for CSDME in Japanese patients with type 2 diabetes mellitus (T2DM) and retinopathy (DR), using optical coherence tomography (OCT) if necessary, by multiple regression analysis. One of the risk factors was BP in awakening.
Seven diabetic Japanese patients with CSDME (group 1) and 124 subjects without CSDME (group 2) with DR on OCT were studied.
The durations of T2DM in groups 1 and 2 were 15 ± 10 years and 20 ± 15 years, respectively. There was no significant difference in sex distribution, duration, age, body mass index (BMI), and HbA1c, lipids (TC, LDL, TC/HDL), creatinine and Hb levels, urinary albumin excretion rate, cigarette smoking, and clinic BP between two groups. Morning systolic home BP (MSHBP) and foveal thickness were significantly (p<0.001) greater in group 1 than in group 2, and visual acuity was significantly (p<0.001) lower in group 1 than group 2. The patients in both groups had received various kinds of drugs for hyperglycemia, hypertension and others. There were no significant differences in the prevalence of other variables between two groups.
On multiple regression analysis, MSHBP and nephropathy were significantly (p <0.03) positive predictors for CSDME, while BMI had a significantly (p <0.001) negative predictor. Other variables were not significantly correlated to CSDME.
Thus, MSHBP is a predictive factor for CSDME that can be added to the previously reported risk factors in patient with T2DM.
Export Options
About this article
Cite this article as:
Kamoi Kyuzi, Takeda Keiji, Hashimoto Kaoru, Tanaka Reiko and Okuyama Shinya, Identifying Risk Factors for Clinically Significant Diabetic Macula Edema in Patients with Type 2 Diabetes Mellitus, Current Diabetes Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573399811309030002
DOI https://dx.doi.org/10.2174/1573399811309030002 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with the increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to the microcirculatory disturbances and the reduced levels of endogenous growth factors. Delayed cutaneous wound healing is ...read more
Oxidative and inflammatory responses in the development of secondary diabetic complications
Diabetes, along with its associated secondary complications, represents a significant global health challenge, contributing significantly to morbidity and mortality. Unhealthy lifestyle habits, reduced physical activity, environmental pollutants, and stress are pivotal factors in the onset of diabetes, particularly type-2 diabetes. Poorly managed hyperglycemia can lead to various complications, including neuropathy, ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Current Pharmaceutical Design Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Current Vascular Pharmacology Medicinal Plants and Bioactive Compounds for Diabetes Management: Important Advances in Drug Discovery
Current Pharmaceutical Design Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews Comparative Study to Characterise the Pharmaceutical Potential of Synthesised Snake Venom Bradykinin-Potentiating Peptides <i>In Vivo</i>
Current Medicinal Chemistry Targeting Vascular Redox Biology Through Antioxidant Gene Delivery: A Historical View and Current Perspectives
Recent Patents on Cardiovascular Drug Discovery Lysophosphatidic Acid and Renal Fibrosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Computational Biological Analysis Reveals a Role for Nitric Oxide Synthase and Adiponectin in the Pathobiology of Insulin Resistance Syndrome and Coronary Artery Disease
Current Nutrition & Food Science Poly-Pharmacy Among the Elderly: Analyzing the Co-Morbidity of Hypertension and Diabetes
Current Pharmaceutical Design Introduction (Transient Receptor Potential TRP Channels as Therapeutic Drug Targets: Next Round!)
Current Topics in Medicinal Chemistry Inflammatory Biomarkers Predicting Events in Atherosclerosis
Current Medicinal Chemistry Biomarkers of Subclinical Atherosclerosis and Natural Products as Complementary Alternative Medicine
Current Pharmaceutical Design The Emerging Role of Endocrine Disruptors in Pathogenesis of Insulin Resistance: A Concept Implicating Nonalcoholic Fatty Liver Disease
Current Molecular Medicine The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
Current Neuropharmacology Vascular Endothelium: Functioning in Norm, Changes in Atherosclerosis and Current Dietary Approaches to Improve Endothelial Function
Mini-Reviews in Medicinal Chemistry The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy
Current Drug Safety Interactions of VIP, Secretin and PACAP1-38 with Phospholipids: A Biological Paradox Revisited
Current Pharmaceutical Design Hypoxic Gas Therapy in Neonatology: Considerations in Practice
Current Drug Discovery Technologies Structure and Inhibitor Binding Mechanisms of 11β -Hydroxysteroid Dehydrogenase Type 1
Current Chemical Biology Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease
Current Respiratory Medicine Reviews